Akash Shukla

Akash Shukla

Auto-generated profile, based on publicly available information

Akash Shukla

Department of Hepatology, Sir HN Reliance Foundation Hospital, Mumbai, Maharashtra, India

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Hepatology International
Verified
Journal Article
Closed access
PDF file
YWYanyan Wu
Yanyan Wu
HLHong-Yu Li
Hong-Yu Li
XGXiaozhong Guo
Xiaozhong Guo
EYEric M. Yoshida
Eric M. Yoshida
Nahum Mendez-SanchezNahum Mendez-Sanchez
Nahum Mendez-Sanchez
XQXingshun Qi
Xingshun Qi

1 June 2021 in Hepatology International
Verified
Journal Article
Closed access
PDF file
ASAkash Shukla
Akash Shukla
ASAnanta Shreshtha
Ananta Shreshtha
AMAmar Mukund
Amar Mukund
CBChhagan Bihari
Chhagan Bihari
CEC. E. Eapen
C. E. Eapen
SSShiv Kumar Sarin
Shiv Kumar Sarin

1 January 2021 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
PPPankaj Puri
Pankaj Puri
RDRadha K. Dhiman
Radha K. Dhiman
STSunil Taneja
Sunil Taneja
PTPuneeta Tandon
Puneeta Tandon
Manuela MerliManuela Merli
Manuela Merli
MWManav Wadhawan
Manav Wadhawan

1 July 2020 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
AAAnil C. Anand
Anil C. Anand
BNBhaskar Nandi
Bhaskar Nandi
SASubrat Kumar Acharya
Subrat Kumar Acharya
AAAnil Arora
Anil Arora
SBSethu Babu
Sethu Babu
MWManav Wadhawan
Manav Wadhawan

18 July 2021 in Hepatology International
Verified
Journal Article
Closed access
PDF file
NVNipun Verma
Nipun Verma
RDRadha Krishan Dhiman
Radha Krishan Dhiman
ACAshok Choudhury
Ashok Choudhury
STSunil Taneja
Sunil Taneja
ADAjay Duseja
Ajay Duseja
APAPASL ACLF Research Consortium (AARC) for APASL ACLF working Party
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party

15 November 2024 in Hepatology International
Verified
Journal Article
Open access
PDF file
ASAkash Shukla
Akash Shukla
DRDon C. Rockey
Don C. Rockey
PKPatrick S. Kamath
Patrick S. Kamath
DKDavid E. Kleiner
David E. Kleiner
ASAnkita Singh
Ankita Singh
SSShiv Kumar Sarin
Shiv Kumar Sarin
Since the Asian Pacific Association for the Study of the Liver (APASL) published guidelines on non-cirrhotic portal fibrosis/idiopathic portal hypertension in 2007, there has been a surge in new information, especially with the introduction of the term porto-sinusoidal vascular disorder (PSVD). Non-cirrhotic intra-hepatic causes of portal hypertension include disorders with a clearly identifiable etiology, such as schistosomiasis, as well as disorders with an unclear etiology such as non-cirrhotic portal fibrosis (NCPF), also termed idiopathic portal hypertension (IPH). This entity is being increasingly recognized as being associated with systemic disease and drug therapy, especially cancer therapy. An international working group with extensive expertise in portal hypertension was assigned with formulating consensus guidelines to clarify the definition, diagnosis, histological features, natural history, and management of NCPF/IPH, especially in the context of PSVD. The guidelines were prepared based on evidence from existing published literature. Whenever there was paucity of evidence, expert opinion was included after detailed deliberation. The goal of this manuscript, therefore, is to enhance the current understanding and help create global consensus on the issues surrounding NCPF/IPH.